Using the right combination of drugs at a critical point in tumor evolution may stop the progression of heterogeneous tumors.
Resistance to initial therapy for patients with CLL may limit treatment options; however, rituximab combined with the PI3K inhibitor idelalisib may offer a tolerable alternative therapy.
Autophagy inhibition may prove to be a valuable tool for overcoming TKI resistance when treating chronic myeloid leukemia.
This fact sheet reviews information on the diagnosis, treatment, grade, and management of follicular lymphoma cancer.
This fact sheet offers tips to help patients with acute chronic myelogenous leukemia overcome challenges to adhering to treatment regimens.
This fact sheet helps patients with acute chronic CML to sort through treatment options, manage side effects, and find financial aid.
This fact sheet educates patients about what causes acute chronic CML and how it can be treated.
This fact sheet on myelofibrosis leukemia symptoms, treatment options and quality of life issues helps newly-diagnosed patients.
A 23-year-old patient with Hodgkin lymphoma was seen as an inpatient consultation for a pruritic rash that had been present ...
By Justin M. Watts, MD; Peter Maslak, MD; Martin S. Tallman, MD
A 47-year-old woman presented for evaluation of pancytopenia. She ...
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|